November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc. (NASDAQ:HUMA) stock and set a price target of $11. Humacyte, Inc.
Humacyte (HUMA): Benchmark Remains Bullish on Stock
view original post
November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc. (NASDAQ:HUMA) stock and set a price target of $11. Humacyte, Inc.